NOTE TO READERS: When this project lost substantial funding at the end of 2018, I lost the ability to continue publishing criteria-driven news story reviews and PR news release reviews - once the bread-and-butter of the site going back to 2006. The 3,200 archived reviews, while still educational, are getting old and difficult for me to technically maintain on the back end of the website. So I am announcing that I plan to remove these reviews from the site by April 1, 2021. The blog and the toolkit - two of the most popular features on the site - will remain. If you wish to peruse the reviews before they disappear, please do so by the end of March 2021. After that date you may still be able to access them via the Internet Archive Wayback Machine - https://archive.org/web/.

WebMD story hypes Levitra

Posted By

Tags

WebMD posted one of those stories that makes my skin crawl. The formula: use a cute, sexy headline and lead sentence, then follow with weak caveats, leaving the reader with nothing useful at the end.

The story is headlined, “Levitra a Day May Keep the Doctor Away.” It promotes Levitra use with its lead sentences, “Men now have two new reasons to take erection-enhancing drugs every day. Those reasons: The drugs may lower a man’s risk of heart disease and of noncancerous prostate symptoms.” But then it follows with, “This provocative speculation is based on short-term data from a small study.” And it ends with, “But it’s not yet time to start popping those little pills along with your daily vitamins. The study findings… are preliminary.”

How do you justify the headline and the lead with the caveats? And this story was reviewed by a physician? Perhaps the editorial and physician review team need to be reminded of the number of preliminary findings presented at scientific meetings (as this was) that never pan out. And when that happens, journalists like these aren’t around to correct the record.

Chalk it up as a waste of time and space. Come back when you have large-scale, long-term findings to report.

You might also like

Comments

Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.

Comments are closed.